Hymenoptera venom allergy in children [Abstract in English]

AIMS: Allergy to hymenoptera venom may restrict a child's life significantly. It is intended, with the exposure of two clinical cases and a brief review on the topic, emphasizing the importance of referral of these children to specialized care for early desensitization. CASES DESCRIPTION: Two c...

Full description

Bibliographic Details
Authors: Santos, Sónia, Loureiro, Carla Chaves, Lemos, Sónia, Pinheiro, José António
Format: article
Status:Published version
Publication Date:2012
Country:Brasil
Institution:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
Repository:Scientia Medica (Porto Alegre. Online)
Language:Portuguese
English
OAI Identifier:oai:ojs.revistaseletronicas.pucrs.br:article/10655
Online Access:https://revistaseletronicas.pucrs.br/scientiamedica/article/view/10655
Access Level:Open access
Keyword:Allergy
Hypersensitivity
Immunotherapy
Desensitization
Immunologic
Wasp Venoms
Bee Venoms
Hymenoptera
Ultra-Rush
Alergia
Hipersensibilidade
Imunoterapia
Dessensibilização Imunológica
Veneno De Vespa
Veneno De Abelha
Himenópteros
Ultra-Rush.
Description
Summary:AIMS: Allergy to hymenoptera venom may restrict a child's life significantly. It is intended, with the exposure of two clinical cases and a brief review on the topic, emphasizing the importance of referral of these children to specialized care for early desensitization. CASES DESCRIPTION: Two children, at three and six years, had anaphylactic reaction to wasp and bee stings, respectively. In both cases, after the determination of specific IgE and allergologic confirmation, desensitization with hymenoptera venom in ultra-rush regimen was done, without relevant side effect apart from swelling at the injection site. After twelve months of injections every four weeks, the children are now receiving maintenance injections every six weeks. In the first case, the child was stung by wasp at ten months of immunotherapy, triggering only small local reaction. CONCLUSIONS: In both cases, the subcutaneous venom immunotherapy with ultra-rush regimen was safe and effective, providing the comfort of a smaller number of injections and hospital visits during the induction phase. Maintenance therapy has demonstrated a protective effect on re-exposure to the poison in one child.